The Israeli Journal of Emergency Medicine (ISRJEM) is a peer-reviewed
Israeli journal that publishes articles of interest to emergency
physicians. ISRJEM is published by the Israeli Association for
Emergency Medicine as part of its mission to its members and the EM
community at large. It is the Association's official journal.
SCOPE AND CONTENT
ISRJEM focuses on content relevant to all aspects of emergency
medicine (EM): clinical, educational, research and administration. It also covers the entire spectrum of emergency medicine
practice and all patient age groups including clinical care,
research and education. We welcome article submissions in the
following categories: Advances (original research), State of the Art
(review articles), Pharmacotherapy, Controversies (commentaries and
special articles), Education, Methodology: the Science of EM, Case
Reports, EM Administration, Letters, Resident Issues, Diagnostic
Challenge, Pediatric EM, Toxicology, Small Urban and Rural Issues,
EMS, resident forum, Humour and Humanity, International EM, and
Media Reviews. ISRJEM publishes articles in English.
Suggested article length is 2000-3000 words for feature articles,
1000-2000 for Case Reports, 600-1800 for Humour and Humanity or
Commentary articles, 500-1000 for Diagnostic Challenge, and 200-400
for Letters. Our goal is that ISRJEM provides high quality content in
a succinct, easy-to-read format; therefore accepted articles may be
edited for clarity and brevity.
Please email ISRJEM with your email address, mailing address, and
profession (Physician, nurse, paramedic, etc) at:
Authors should conform to the general guidelines laid out in the Uniform
Requirements for Manuscripts Submitted to Biomedical Journals
(1). Articles prepared in accordance with these guidelines will not
be rejected for reasons of style or format.
Formatting: Manuscripts should be double-spaced throughout, from title
page to references. Authors should use a consistent 12-point font,
preferably Times New Roman. Right margins should be unjustified
(ragged). Special formats, including Endnotes, superscripts,
subscripts, small caps, paragraph adjustment and auto-numbering
should be avoided, as all make the editorial process more difficult.
Number the pages consecutively, beginning with the title page, and
provide a running header.
Title page: The title page should include the article title, the authors'
name(s) as they should appear in print, and the affiliations of all
authors. The name, address, telephone number, fax number, and email
address for the corresponding author should be provided, running
header or footer, key MeSH
words, in addition to a word count. The
next page should include the group authorship, disclaimers, sources
of support and acknowledgment.
Abstracts: Structured abstracts (Objectives, Methods, Results,
Conclusions) of up to 250 words are required for original research
articles, systematic review articles and meta-analyses. Unstructured
abstracts should be provided for case reports, commentaries and most
other articles. The latter should summarize the problem or
objective, main points, and conclusions of the article in 150-200
words. Abstracts are not required for editorials, news items or
Humour and Humanity pieces.
Ethical considerations: For investigations involving human subjects,
the "Methods" section should specify the nature of the
patient consent that was obtained at the time of enrolment. Authors
must clarify that an appropriate ethics committee or investigational
review board approved the research.
References: Within the text, references should be numbered in the
order they appear, using standard text and angular brackets rather
than superscript. Avoid special formats, including auto-numbering
for sections or references. References should report all authors up
to 6. When there are more than 6 authors, the first 6 should be
cited, followed by "et al."
Electronic submission by email or CD ROM
required. Manuscripts submitted as email attachments should be
forwarded to email@example.com,
in Microsoft Word format. All submissions should be accompanied by a
brief cover letter. Within the cover letter, the corresponding
author should identify potential conflicts of interest, specify each
author's contribution to the work, and indicate that all co-authors
have provided their permission to publish the manuscript.
Photographs and digital image files are acceptable. If figures are
submitted electronically they must meet the specifications outlined
in the Canadian
Medical Association Publications' Digital Art Submission form.
If figures, illustrations or tables have been taken or adapted from
a previous publication, the authors are responsible to acquire
written permission from the publishers to reproduce these items. If
patients could possibly be identified by photographs or descriptions
within the manuscript, authors are responsible to acquire written
consent from the patients to publish their photographs or
In accordance with "Uniform Requirements"(1), manuscripts will
be considered with the understanding by ISRJEM that they have not been
previously published nor are under consideration by another journal.
Authors are referred to "Uniform requirements" for
detailed guidelines on previous publication and exceptions.
Review and editorial processes
All submissions are reviewed by the editor-in-chief or a senior associate
editor within 2 weeks. Articles that are clearly unsuitable for ISRJEM
will be returned to the authors at this time. Those considered
relevant to EM will be forwarded for blinded peer review. Peer
review comments will be forwarded electronically to a decision
editor, who will decide whether the article should be accepted,
rejected or revised. This editor will compose an editor's response
letter to the author. In most cases, authors can expect an editor's
response within 6-8 weeks of original manuscript submission.
Revised manuscripts will be forwarded to the decision editor, who will
determine whether review comments have been addressed. The decision
editor, often in concert with the editor-in-chief or senior
associate editor will make a final decision regarding publication.
Accepted articles will be edited for clarity, brevity and style, and
authors will have the opportunity to review and approve revisions
prior to publication. Manuscripts submitted to ISRJEM will be treated
with respect and confidentiality. After acceptance, transfer of
copyright must be made in writing to the ISRJEM.
Financial disclosure (conflict of interest)
Prior to publication, all authors will be required to sign a financial
disclosure form, indicating any financial interests or potential
conflicts of interest they have relating to the manuscript.
Additional instructions: To submit to specific ISRJEM sections:
EM Advances: EM advances accepts articles that present primary
data arising from original research. Authors of randomized clinical
trials should conform to the criteria specified in the CONSORT
statement (2) checklist. The revised CONSORT statement can be viewed
Authors of retrospective reviews should, where appropriate,
incorporate the design elements discussed by Gilbert and colleagues
(3). "EM Advances" articles should be from 2000-3000
words, excluding tables, figures and references. The Introduction
should discuss study justification, and a priori objectives and
hypotheses. The Methods section should include a description of the
overall study design, the study setting, time period, patients
studied (with eligibility criteria), a description of the
intervention, the primary and secondary outcome measures, and the
statistical analysis employed. The Results section should include
primary and secondary results, with appropriate tables and figures.
The Discussion section should highlight the important study findings
and discuss these in the context of previous published literature.
In addition, the Discussion should identify limitations of the
research and future directions. Conclusions should be stated in 1
paragraph and should be supported by the data. A structured Abstract
should be prepared (see above).
State of the Art (review articles): "State of the Art" is
devoted to topical reviews of the recent and past scientific
literature. Review articles should attempt to define the "state
of the art" for the topic or research question addressed.
Systematic reviews are preferred, but narrative reviews will be
considered for publication. All articles or data sources should be
selected systematically for inclusion in the review and critically
evaluated, and the selection process should be described in the
paper. Expected length for a "State of the Art" review is
3000-4000 words (not including tables, figures and references).
Authors of systematic reviews incorporating meta-analysis should
refer to the QUOROM statement on improving the quality of reports of
meta-analysis of randomized controlled trials.4 Authors of
systematic reviews without meta-analysis should refer to the
systematic review series edited by Cook and colleagues (5) and
Mulrow et all (6).
Authors of systematic review articles should: define a clear and
clinically relevant research question; retrieve and describe
relevant reviews published to date; document their limitations and
justify the need for a more comprehensive review (7); define the
search strategy used to identify primary articles (8); describe the
methods used to select primary studies; specify inclusion and
exclusion criteria (criteria for selecting primary studies should be
based on population studied, intervention or exposure, study
outcomes, and study methodology); perform a blinded assessment of
the quality of the selected articles; assess the reliability of this
process by measuring the agreement of 2 evaluators (9,10); account
for all studies identified by the search and justify exclusions;
describe the method of combining study results; discuss variation
within and between studies; state their conclusions; compare their
conclusions to the literature and current standard of care; outline
the limitations of the review; suggest areas for future research.
The Abstract for a systematic review should include the following
headings: Objectives, Data source, Study selection, Data extraction,
Data synthesis, and Conclusion.
Pharmacotherapy: The goal of the "Pharmacotherapy" section
is to provide evidence-based reviews of current trends in
pharmacology and therapeutics, and of drug therapies commonly used
in the emergency department. Reviews may focus on new pharmaceutical
modalities relevant to the emergency department or on new
indications for older medications.
Reviews should include a brief Introduction discussing the
background of the agent(s) under review and defining the paper's
objective. This should be followed by a Pharmacology and
pharmacokinetics section that includes comparisons to other drugs
within the same class should also be included if possible. This
section should not be over detailed but sufficient enough to allow
the prescriber to understand the basic pharmacology (mechanism) of
the new agent and appreciate some of the pharmacokinetic principles
that dictate dosing of the agent (e.g., onset, duration, clearance
[renal vs. hepatic], half-life). A section on Clinical evidence
should encompass most of the paper and should critically evaluate
the current evidence that surrounds the use of this agent. The
author should be encouraged to provide a thorough review of the
literature to ensure all pertinent literature on the topic is
captured. The author should then be able to consolidate the current
evidence on both efficacy and safety and cost on the use of this
agent as well as limitations and unanswered questions that arise
from the current literature on the topic of focus. Finally, the
author should outline the current role of the agent of focus as it
pertains to use in the emergency department. The current place in
therapy compared to the standard of care should be outlined with
final recommendations on indications, dose, route and duration of
care along with appropriate monitoring parameters.
"Selected Articles" is devoted to evidence-based article
reviews. The aims of this section are to demonstrate the use of the
critical review format, to review articles of interest to emergency
physicians, and to determine the relative validity and usefulness of
these articles. Review articles address 3 key questions: What are
the results? Are the results valid? and will the results help me
care for my patients? In each issue of ISRJEM, we hope to
have important articles reviewed by emergency physicians with a
special interest or expertise in the topic under discussion. The
preferred review methodology, including critical review forms, is
described in "Users
Guide to the Medical Literature," a series published in the
Journal of the American Medical Association. Authors wishing to view
samples of appropriate article review format may visit the NHS
Research and Development
Centre for Evidence-Based Medicine Web site
(http://cebm.jr2.ox.ac.uk) or peruse articles published in ACP
Journal Club. CATs and selected article reviews are selected for
publication based on the quality of the review and the topic's level
of interest to emergency physicians.
Case Reports: Case reports are most valuable if they illustrate an
important error or practice point for emergency physicians, if they
identify a previously not described finding or phenomenon, or if
they describe a therapy that could lead to future research or a
change in practice. Suggested article length for case reports is
1000-2000 words. Our goal is that ISRJEM provides high quality content
in an easy-to-read format; therefore brevity and active voice are
encouraged. Authors should conform to the general guidelines laid
out in "Uniform Requirements" (1). Manuscripts submitted
to "Case Reports" should include: 1. a brief Introduction
(1-2 paragraphs describing why the topic is important); 2. the Case
Report, consisting of a succinct summary of relevant historical,
physical, laboratory and imaging findings, emergency department
diagnosis, management, and disposition, and relevant follow-up
information (e.g., patient outcome, findings at laparotomy); 3. a
Discussion, summarizing what the case illustrates and what the
teaching points are; 4. a 1-paragraph Conclusion.
Brief Reports: Brief reports of original studies should be 650-1200 words
excluding tables, figures and references. Brief reports will be
limited to 1 table or figure and 10 references.
Letters: Letters should be addressed to the editor, ISRJEM. Letters will be
considered for publication if they relate to topics of interest to
emergency physicians in urban, rural, community or academic
settings. Letters are generally not peer reviewed but may be edited
for brevity and clarity. Letters will generally be limited to 400
words and 5 references. Letters responding to a previously published
ISRJEM article should reach ISRJEM head office within 6 weeks of the
article's publication. Authors whose work is discussed will be given
an opportunity to respond.
Break in the Action: Submissions should reflect the challenges of working
in medicine. Generally they should add to our understanding of the
physician experience, particularly in Israel. Articles are peer
reviewed and are to be less than 1000 words in length.
Images in Medicine: Photographic submissions should be of relevance to
the practice of emergency medicine. These may include diagnostic
challenges (with accompanying text) or images that are reflective of
the cultural and operational aspects of emergency medicine. Images
should be of sufficient resolutions to reproduce at 1200 x 1024
(minimum 2 mega pixel), and be transmitted electronically.
Photography displaying the face or recognizable features of human
subjects requires a signed copy of the Photography
under in exceptional cases will ISRJEM publish material that has
appeared elsewhere. Under these circumstances, the authors must
abide by the following:
International Committee of Medical Journal Editors states the
III.D.3. Acceptable Secondary Publication
Certain types of articles, such as guidelines produced by
governmental agencies and professional organizations, may need to
reach the widest possible audience. In such instances, editors
sometimes choose deliberately to publish material that is also being
published in other journals, with the agreement of the authors and
the editors of those other journals. Secondary publication for
various other reasons, in the same or another language, especially
in other countries, is justifiable, and can be beneficial, provided
all of the following conditions are met.
1. The authors have received approval from the editors of both
journals; the editor concerned with secondary publication must have
a photocopy, reprint, or manuscript of the primary version.
2. The priority of the primary publication is respected by a
publication interval of at least one week (unless specifically
negotiated otherwise by both editors).
3. The paper for secondary publication is intended for a different
group of readers; an abbreviated version could be sufficient.
4. The secondary version faithfully reflects the data and
interpretations of the primary version.
5. The footnote on the title page of the secondary version informs
readers, peers, and documenting agencies that the paper has been
published in whole or in part and states the primary reference. A
suitable footnote might read: "This article is based on a study
first reported in the [title of journal, with full reference]."
Permission for such secondary publication should be free of charge.
6. The title of the secondary publication should indicate that it is
a secondary publication (complete republication, abridged
republication, complete translation, or abridged translation) of a
primary publication. Of note, the National Library of Medicine does
not consider translations to be "republications," and does
not cite or index translations when the original article was
published in a journal that is indexed in MEDLINE.
CONTACTING ISRJEM EDITORS
Prospective authors with questions regarding a submission, or those who
wish to discuss a paper in the development stage are encouraged to
contact the editor-in-chief
or the appropriate section editor listed in the Appendix below.
Email correspondence is preferred.
1. International Committee of Medical Journal Editors. Uniform
requirements for manuscripts submitted to biomedical journals.
2. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al.
Improving the quality of reporting of randomized controlled trials:
the CONSORT statement. JAMA 1996;276(8):637-9
3. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J.
Chart reviews in emergency medicine research: Where are the methods?
Ann Emerg Med 1996;27:305-8
4. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF.
Improving the quality of reports of meta-analyses of randomised
controlled trials: the QUOROM statement. Lancet 1999;354:1896-900
5. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of
best evidence for clinical decisions. Ann Intern Med 1997;126:376-80
6. Mulrow C, Langhorne P, Grimshaw J. Integrating heterogeneous
pieces of evidence in systematic reviews. Ann Intern Med
7. Hunt DL, McKibbon KA. Locating and appraising systematic reviews.
Ann Intern Med 1997;126:532-8
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan
DJ, et al. Assessing the quality of reports of randomized clinical
trials: Is blinding necessary? Control Clin Trials 1996;17:1-12
10. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA.
Incorporating variations in the quality of individual randomized
trials into meta-analysis. J Clin Epidemiol 1992;45:255-65